(6R,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98%

cas: 50370-12-2 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

(6R,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 98% (CAS 50370-12-2) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 100mg, 250mg, 1g. Oferty producentów: BLDpharm.

• 2D
• 3D

(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS 50370-12-2) to związek chemiczny o wzorze sumarycznym C16H17N3O5S i masie molowej 363.4 g/mol. Nazwa systematyczna IUPAC: (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. InChIKey: BOEGTKLJZSQCCD-UEKVPHQBSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C16H17N3O5S
Masa molowa	363.4 g/mol
Nazwa IUPAC	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChIKey	BOEGTKLJZSQCCD-UEKVPHQBSA-N
SMILES	CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: cefadroxil, Cephadroxil, Cefadroxil anhydrous, Cefadroxilo, Cefadroxilum, D-Cefadroxil, Duricef, Anhydrous cefadroxil, Ultracef, Cefadrops

Powiązane formy tego związku

(6R,7R)-7-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S

Izomery (ten sam wzór sumaryczny)

4-[3-(4,5-dihydro-1,2-oxazol-3-yl)-2-methyl-4-methylsulfonylbenzoyl]-2-methyl-1H-pyrazol-3-one C₁₆H₁₇N₃O₅S

(5S,6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-5,8-dioxo-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S

(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-5,8-dioxo-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S

2-methoxy-N-[4-(methylcarbamoylamino)phenyl]sulfonylbenzamide C₁₆H₁₇N₃O₅S

(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S

(5R,6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-5,8-dioxo-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S

(6R,7R)-7-[[(2R)-2-amino-2-(2-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S

2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5-methyl-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid C₁₆H₁₇N₃O₅S

N-(2-morpholin-4-ylphenyl)-2-nitrobenzenesulfonamide C₁₆H₁₇N₃O₅S

N-(1,3-benzodioxol-5-ylmethyl)-2-(2,4-dioxo-7-thia-1,3-diazaspiro[4.4]nonan-3-yl)acetamide C₁₆H₁₇N₃O₅S

(6R,7R)-7-[(2-amino-2-phenylacetyl)amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C₁₆H₁₇N₃O₅S